Ambria Capital invests into emerging public and private companies in the legal cannabis, hemp and CBD industries. With holdings in the agriculture, consumer, healthcare, and technology verticals, Ambria provides funding through a company-specific mix of debt and equity financing, bridge notes, direct equity purchases, and asset backed loans. Founded in 2019 by a team of investment professionals with decades of success in the small cap markets, Ambria Capital combines a comprehensive analytical approach with an unparalleled network of contacts, connecting cannabis industry leaders with market opportunities.